Review Article

Regulatory, Review Article

Evolution of the Medicare Part D Medication Therapy Management Program from Inception in 2006 to the Present

Cori Gray, PharmD, Catherine E. Cooke, PharmD, MS (PHSR), BCPS, PAHM, Nicole Brandt, PharmD, MBA, BCPP, BCGP, FASCP

Stakeholder Perspective

Successes and Challenges of the Medicare Part D MTM Program

by Jack E. Fincham, PhD, RPh

Clinical, Review Article

The Challenge of Managing Atopic Dermatitis in the United States

Steven R. Feldman, MD, PhD, Linda S. Cox, MD, Lindsay C. Strowd, MD, Robert A. Gerber, PharmD, MA, MBA, Steven Faulkner, PharmD, MBA, Debra Sierka, PharmD, Timothy W. Smith, BA, Joseph C. Cappelleri, PhD, Mark E. Levenberg, DO

Stakeholder Perspective

Evolving Therapies for Atopic Dermatitis Will Create New Management Challenges

by Gary M. Owens, MD

Business, Review Article

Standardized Review and Approval Process for High-Cost Medication Use Promotes Value-Based Care in a Large Academic Medical System

Raghu Durvasula, MD, MHA, Janet Kelly, PharmD, Anneliese Schleyer, MD, MHA, Bradley D. Anawalt, MD, Shabir Somani, MS, MBA, RPh, FASHP, Timothy H. Dellit, MD

Stakeholder Perspective

Pharmacy & Therapeutics Committees’ New Challenge: Stewardship for Specialty Drugs

by Byron C. Scott, MD, MBA

Results 1 - 3 of 3

Copyright © Engage Healthcare Communications, LLC. All rights reserved.